10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2019-11-14 (Q3 2019) | Holdings: 109 | Value: $14.7B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seattle Genetics, Inc. | 29.08% | $4.3B | +5.27% | +55.48% | |||
| INCY - Incyte Corporation | 16.15% | $2.4B | -24.75% | -8.28% | -2.44% | ||
| ACAD - ACADIA Pharmaceuticals Inc. | Add 4% ($56.2M) | 10.00% | $1.5B | -52.98% | -0.94% | +19.10% | |
| BGNE - BeiGene, Ltd. | 9.81% | $1.4B | +21.54% | -15.47% | +38.56% | ||
| ALXN - Alexion Pharmaceuticals, Inc. | 5.50% | $808.8M | -4.38% | +19.63% | |||
| AMRN - Amarin Corporation plc | 4.28% | $629.8M | -97.51% | -21.76% | -79.83% | ||
| GHDX - Genomic Health, Inc. | 4.27% | $627.0M | |||||
| BMRN - BioMarin Pharmaceutical Inc. | 3.48% | $511.5M | -23.59% | +17.03% | +1.46% | ||
| ASND - Ascendis Pharma A/S | 2.22% | $326.6M | +46.06% | +27.05% | +47.45% | ||
| NVTA - Invitae Corporation | Add 125% ($94.2M) | 1.15% | $169.4M | +51.05% | +157.21% | ||
| KOD - Kodiak Sciences Inc. | 0.89% | $131.5M | -86.60% | +132.24% | +347.62% | ||
| NBIX - Neurocrine Biosciences, Inc. | 0.87% | $127.5M | +12.27% | -4.41% | -15.17% | ||
| ARGX - argenx SE | 0.79% | $116.2M | +316.49% | +16.33% | +87.81% | ||
| HRTX - Heron Therapeutics, Inc. | 0.76% | $111.3M | -91.07% | +0.40% | -12.78% | ||
| MRTX - Mirati Therapeutics, Inc. | Reduce 48% $(94.0M) | 0.69% | $101.8M | -6.70% | +121.15% | ||
| MDGL - Madrigal Pharmaceuticals, Inc. | 0.69% | $100.8M | +176.50% | -8.07% | +21.48% | ||
| MYOK - MyoKardia, Inc. | Add 49% ($26.1M) | 0.54% | $79.1M | +34.15% | +326.69% | ||
| ONCE - Spark Therapeutics, Inc. | 0.50% | $72.9M | |||||
| TCDA - Tricida, Inc. | 0.41% | $60.8M | +2.31% | -81.69% | |||
| RYTM - Rhythm Pharmaceuticals, Inc. | 0.40% | $58.5M | +182.63% | -16.50% | +0.88% | ||
| IGMS - IGM Biosciences, Inc. | New Purchase | 0.38% | $55.8M | -95.31% | +67.05% | +99.26% | |
| RARX - Ra Pharmaceuticals, Inc. | Add 30% ($12.9M) | 0.38% | $55.5M | +0.02% | |||
| CERS - Cerus Corporation | 0.38% | $55.4M | -70.94% | +9.61% | +38.44% | ||
| DBVT - DBV Technologies S.A. | 0.32% | $47.4M | -88.65% | +31.52% | -66.17% | ||
| PRNB - Principia Biopharma Inc. | Reduce 7% $(3.8M) | 0.32% | $46.7M | +124.99% | |||
| BCEL - Atreca, Inc. | 0.29% | $43.2M | +103.51% | +41.04% | |||
| GWPH - GW Pharmaceuticals plc | 0.29% | $42.7M | +16.51% | +12.21% | |||
| ZYME - Zymeworks Inc. | 0.29% | $42.4M | -68.31% | +33.77% | +15.36% | ||
| BOLD - Audentes Therapeutics, Inc. | 0.29% | $42.3M | |||||
| N/A - Neurocrine Biosciences, Inc. | 0.29% | $42.1M | |||||
| INSM - Insmed Incorporated | Reduce 9% $(4.1M) | 0.27% | $39.3M | +259.43% | +56.88% | +89.12% | |
| BCRX - BioCryst Pharmaceuticals, Inc. | Reduce 12% $(4.7M) | 0.25% | $36.5M | +532.35% | +72.06% | +161.76% | |
| ADPT - Adaptive Biotechnologies Corporation | 0.24% | $36.0M | -65.06% | +16.51% | +71.38% | ||
| KRYS - Krystal Biotech, Inc. | 0.24% | $35.9M | +146.45% | +21.72% | -19.37% | ||
| NLTX - Neoleukin Therapeutics, Inc. | New Purchase | 0.22% | $32.2M | ||||
| CBAY - CymaBay Therapeutics, Inc. | 0.20% | $29.2M | -69.37% | +45.76% | |||
| ALLK - Allakos Inc. | New Purchase | 0.18% | $26.7M | -17.47% | +29.84% | ||
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.16% | $23.8M | +324.19% | +178.29% | +146.82% | ||
| MRUS - Merus N.V. | 0.14% | $20.7M | +250.66% | +19.76% | -14.63% | ||
| QURE - uniQure N.V. | 0.14% | $20.4M | -72.54% | +19.02% | -16.51% | ||
| URGN - UroGen Pharma Ltd. | New Purchase | 0.12% | $17.8M | -83.85% | +13.86% | -12.60% | |
| AXSM - Axsome Therapeutics, Inc. | 0.11% | $15.6M | +297.43% | +248.00% | +180.76% | ||
| N/A - BioMarin Pharmaceutical Inc. | 0.10% | $14.7M | |||||
| XNCR - Xencor, Inc. | 0.10% | $14.4M | -77.86% | -0.75% | +12.29% | ||
| AIMT - Aimmune Therapeutics, Inc. | 0.10% | $14.1M | +3.54% | ||||
| PTGX - Protagonist Therapeutics, Inc. | Add 18% ($2.2M) | 0.10% | $14.1M | +337.92% | -20.76% | +102.58% | |
| LJPC - La Jolla Pharmaceutical Company | 0.09% | $13.7M | +36.16% | -21.82% | |||
| IDRA - Idera Pharmaceuticals, Inc. | 0.09% | $13.3M | -20.00% | +28.37% | |||
| AGLE - Aeglea BioTherapeutics, Inc. | 0.09% | $13.2M | -92.29% | +3.28% | +22.57% | ||
| ALKS - Alkermes plc | New Purchase | 0.08% | $12.2M | +55.00% | -12.26% | -11.11% | |
| ACOR - Acorda Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| NLTX - Aquinox Pharmaceuticals, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| ARRY1 - Array BioPharma Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| ASMB - Assembly Biosciences, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| MRKR - Marker Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||